18-year old patient with extrahepatic biliary duct carcinoid – case report

• Authors: Cezary Rykała , Jacek Bartosiewicz , Jacek Pawlak , Agnieszka Nawrocka-Kunecka , Aleksandra Omulecka
• Languages of publication: EN

Abstracts

EN

Most patients with obstructive jaundice caused by an etiology other than choledocholithiasis are at risk of adenocarcinoma development. Other types of tumors are less common, although more benign. The presented study described management in case of liver hilar tumors with special regards to common hepatic duct carcinoids

Keywords

EN

biliary duct tumors; choledocholithiasis; neuroendocrine tumors; mechanical jaundice

• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2015
• Volume: 86
• Issue: 1
• Pages: 39-43

Dates

published

1 - 01 - 2014

online

27 - 02 - 2014

Contributors

author

Cezary Rykała

• Department of General Surgery, John Paul II Western Hospital in Grodzisk Mazowiecki

author

Jacek Bartosiewicz

• Department of General Surgery, John Paul II Western Hospital in Grodzisk Mazowiecki

author

Jacek Pawlak

• The histopathological examination was performed and the diagnosis establish at ZOZ Olympus Consilio

author

Agnieszka Nawrocka-Kunecka

• The histopathological examination was performed and the diagnosis establish at ZOZ Olympus Consilio

author

Aleksandra Omulecka

• The histopathological examination was performed and the diagnosis establish at ZOZ Olympus Consilio

References

• 1. Vinik AI : Neoplasms of the Gastroenteropancreatic Endocrine System. In: Cancer medicine. Philadelphia, PA: Lea and Febiger 1993; 1180-1209.
• 2. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97(4): 934-59.
• 3. Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79(4): 813-29.[PubMed]
• 4. Blechacz B, Goves GJ: Cholangiocarcinoma: advances in pathogenesis, diagnosis and treatment.Hepathology 2008; 48: 308-21.[Crossref]
• 5. K imura W, Kuroda A, Morioka Y: Clinical pathology of endocrine tumours of the pancreas: analysis of autopsy cases. Dig Dis Sci 2004; 36: 933-42.
• 6. H emminki K, Li X: Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 2001; 94: 2204-10.
• 7. C hristine AC : Three cases illustrating the presence of argentaffin (kultschitzky) cells in the human gall-bladder. J Clin Pathol 1954; 7(4): 318-21.
• 8. Pilz E: Uber ein karzinoid des ductus choledocus.Zbl Chir 1961; 86:1588-90.
• 9. Felekouras E, Petrou A, Bramis K: Malignant carcinoid tumor of cystic duct: a rare cause of bile duct obstruction. Hepatobilary Pancreatic Dis Int 2009; 8(6): 640-46.
• 10. S omani A, Jain AK , Dixit VK: Periampullary carcinoid: an uncommon tumor at an unusual site.Indian J Cancer 2011; 48(4): 496-99.[WoS]
• 11. Biswan A, Husain E, Feakins RM: Heterotopic pancreas mimicking cholangiocarcinoma. Case report and literature review. J Pancreas 2007; 8(1): 28-34.
• 12. Alexander IA , Thomson KR , Kune GA: Primary common bile duct carcinoid demonstration by computerised tomography, ultrasonography and angiography.Australas Radiol 1986; 30: 34-37.[Crossref][PubMed]
• 13. Hatzitheokiltos E, Buchler MW, Friess H et al.: Carcinoid of the ampulla of Vater: Clinical characteristics and morphologic features. Cancer 1994; 73: 1580-88.[Crossref]
• 14. Feldman JM: Carcinoid tumour and syndrome. 1987; 14: 237-46.[PubMed]
• 15. Mergener K, Gottfried MR, Feldman JM et al.: Carcinoid of the ampulla of Vater presenting as acute pancreatitis. Am J Gastroenterol 1996; 91: 2426-27.[PubMed]
• 16. Larghi A, Tringali A, Lecca PG at al.: Management of hilar biliary strictures. Am J Gastroenterol 2008; 103: 458-73.[Crossref]
• 17. Klein A, Clemens J, Cameron J: Periampullary neoplasms in von Recklinghausen’s disease. Surgery 1989; 206: 815-19.
• 18. Smereczyński A, Bernatowicz E, Starzyńska T: Ultrasonograficzne trudności w rozpoznaniu stwardniającego zapalenia krezki. Ultrasonografia 2010; 41: 29-35.
• 19. Kos-Kudła B, Zemczak A: Polskie zalecenia diagnostyczno-lecznicze w guzach neuroendokrynnych układu pokarmowego (GEP NET). Endokrynol Pol 2006; 57(3): 267-72.
• 20. Ramage JK , Davies AH , Ardill J: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005; 54(4): 1-16.[WoS]
• 21. http: //www.nccn.org/professionals/physician_ gls/pdf/neuroendocrine.pdf
• 22. J anson ET, Sørbye H, Welin S: Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol 2010; 49(6): 740-56.[WoS]
• 23. Öberg K, Åkerström G, Rindi G: Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(5): 223-27.[Crossref]

Identifiers

DOI

10.2478/pjs-2014-0007